NuVasive, Inc. (NUVA) Tops Q1 EPS by 5c; Raises FY11 Outlook
Tweet
Share
E-mailGet Alerts NUVA Hot Sheet
Price: $39.75 --0%
Financial Fact:
Interest expense: -10.98M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest expense: -10.98M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
NuVasive, Inc. (NASDAQ: NUVA) reported Q1 EPS of $0.24, $0.05 better than the analyst estimate of $0.19. Revenue for the quarter came in at $124.5 million versus the consensus estimate of $123.14 million.
NuVasive, Inc. sees FY11 EPS of $1.20-$1.23, versus the consensus of $1.09. NuVasive, Inc. sees FY11 revenue of $530-$540 million, versus the consensus of $530.61 million. The company had previously expected EPS of $1.07-$1.10 on sales of $525-$535 million.
NuVasive, Inc. sees FY11 EPS of $1.20-$1.23, versus the consensus of $1.09. NuVasive, Inc. sees FY11 revenue of $530-$540 million, versus the consensus of $530.61 million. The company had previously expected EPS of $1.07-$1.10 on sales of $525-$535 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Innovaro (INV) Misses Q2 EPS by 9c
- Coherent, Inc. (COHR) Tops Q4 EPS by 12c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
